3.2 Pneumonias, Aspiration Pneumonia, and Influenza

3.2 Pneumonias, Aspiration Pneumonia, and Influenza

Quick Summary: Pulmonary infections represent one of the most frequent reasons for acute hospital admission. On the AHIMA CCS examination, candidates must exhibit expertise in distinguishing infectious bacterial and viral pneumonias (categories J12–J18) from aspiration pneumonitis (category J69), navigating influenza combination codes with respiratory and central nervous system manifestations (categories J09–J11), and applying strict coding conventions for Ventilator-Associated Pneumonia (VAP, code J95.851).

---

Bacterial, Viral, and Fungal Pneumonias (J12–J18)

ICD-10-CM classifies infectious pneumonia according to the specific etiologic pathogen identified and documented by the attending provider.

+-------------------------------------------------------------------------+
|                   PNEUMONIA CLASSIFICATION SPECTRUM                     |
+-------------------------------------------------------------------------+
| BACTERIAL PNEUMONIA (J13 - J15)                                         |
| - Streptococcus pneumoniae: J13                                         |
| - Haemophilus influenzae: J14 | Klebsiella pneumoniae: J15.0                                    |
| - Pseudomonas aeruginosa: J15.1                                         |
| - MSSA: J15.211 | MRSA: J15.212                                         |
| - Other Gram-negative bacilli (E. coli, Serratia, Proteus): J15.69       |
+-------------------------------------------------------------------------+
| VIRAL PNEUMONIA (J12)                                                   |
| - Adenoviral: J12.0 | RSV: J12.1 | Parainfluenza: J12.2                 |
| - COVID-19 associated pneumonia: U07.1 + J12.82                         |
+-------------------------------------------------------------------------+
| INFLUENZA WITH PNEUMONIA (J09 - J11)                                    |
| - Novel / Avian Influenza: J09.X1                                       |
| - Identified Seasonal Flu A/B: J10.0-                                   |
| - Suspected / Unidentified Flu: J11.0-                                  |
+-------------------------------------------------------------------------+
| ASPIRATION PNEUMONITIS (J69.0) - MCC IN CMS MS-DRG v43.1*              |
| - Inhalation of food, gastric secretions, vomit, saliva, liquids        |
+-------------------------------------------------------------------------+
| VENTILATOR-ASSOCIATED PNEUMONIA (J95.851)                               |
| - Hospital-acquired post-intubation complication + Organism code        |
+-------------------------------------------------------------------------+

1. Bacterial Pneumonia Codes

• J13: Pneumonia due to Streptococcus pneumoniae (Pneumococcal pneumonia; lobar pneumonia due to S. pneumoniae).
• J14: Pneumonia due to Haemophilus influenzae.
• J15.0: Pneumonia due to Klebsiella pneumoniae (frequently seen in chronic alcoholics, diabetics, and hospitalized patients).
• J15.1: Pneumonia due to Pseudomonas (common hospital-acquired pathogen, cystic fibrosis, bronchiectasis).
• J15.211: Pneumonia due to Methicillin susceptible Staphylococcus aureus (MSSA).
• J15.212: Pneumonia due to Methicillin resistant Staphylococcus aureus (MRSA).
• J15.69: Pneumonia due to other Gram-negative bacteria (e.g., Escherichia coli, Serratia marcescens, Proteus mirabilis, Enterobacter).
• J15.7: Pneumonia due to Mycoplasma pneumoniae (Walking pneumonia; atypical pneumonia).
• J15.8: Pneumonia due to other specified bacteria (e.g., Legionnaires' disease is coded to A48.1, which contains an instructional note to assign also the manifestation).
• J18.9: Pneumonia, unspecified organism (Community-Acquired Pneumonia / CAP unspecified).
• J18.1: Lobar pneumonia, unspecified organism.

2. Viral and Fungal Pneumonias

• Viral Pneumonias (J12.0–J12.9): Includes Respiratory Syncytial Virus (J12.1), Parainfluenza (J12.2), Human metapneumovirus (J12.3), and other viral agents.
• COVID-19 Associated Pneumonia: Per Section I.C.1.g guidelines, when a patient is admitted with pneumonia confirmed due to COVID-19, assign code U07.1 (COVID-19) as principal diagnosis, followed by code J12.82 (Coronavirus disease 2019 associated pneumonia).
• Fungal Pneumonias: Coded to specific mycoses chapters: Pneumocystis jirovecii pneumonia (B59, common in HIV/AIDS patients), Histoplasmosis pneumonia (B39.0–B39.2), and Coccidioidomycosis (B38.0–B38.2).

[!CAUTION] Diagnostic Coding Clinic Mandate on Laboratory Results: Coders CANNOT code a specific bacterial pneumonia based solely on a positive sputum culture or tracheal aspirate (e.g., sputum showing heavy growth of Pseudomonas or Klebsiella) without explicit provider documentation in the record confirming that the patient has pneumonia due to that specific organism. Coding purely from diagnostic reports without clinical confirmation constitutes non-compliant coding.

---

Aspiration Pneumonia vs. Chemical Pneumonitis vs. Infectious Pneumonia

Aspiration pneumonia is one of the most critical topics on the CCS examination due to its profound impact on MS-DRG grouping and case-mix index.

Clinical and Coding Dynamics of Aspiration Pneumonia (J69.0)

• Code Title: J69.0 (Pneumonitis due to inhalation of food and vomit).
• Includes: Aspiration pneumonia (due to food, gastric contents, saliva, vomitus), Mendelson's syndrome.
• Excludes 1 Note: Neonatal aspiration syndromes (P24.-), chemical pneumonitis due to anesthesia during labor/delivery (O74.0).
• MS-DRG Severity Is Version-Specific: In CMS MS-DRG v43.1, both J69.0 and many bacterial pneumonia codes—including J18.9—are MCCs when reported as secondary diagnoses, subject to exclusions and the complete grouper logic. Do not infer severity from the clinical label or memorize an older list; verify the exact code in the grouper version applicable to the discharge.
• Dual Diagnosis (Aspiration with Superimposed Bacterial Infection): When the provider documents that the patient suffered aspiration pneumonia with secondary bacterial infection (e.g., Klebsiella or MRSA), code J69.0 is sequenced first, accompanied by the secondary bacterial pneumonia code (J15.0 or J15.212).

---

The asterisked severity statements describe CMS MS-DRG v43.1 and remain subject to the CC/MCC exclusion list and complete grouper logic.

Influenza Guidelines & Combination Codes (J09, J10, J11)

ICD-10-CM utilizes an etiology/manifestation combination coding structure for influenza. The coder must understand the distinction between confirmed novel, confirmed seasonal, and unconfirmed influenza.

+-------------------------------------------------------------------------+
|                        INFLUENZA CODING MATRIX                          |
+-------------------------------------------------------------------------+
| CATEGORY J09: Confirmed Novel / Avian Influenza                         |
| - Code only laboratory-confirmed cases of avian or novel strains        |
| - "Suspected", "probable", or "rule out" novel flu -> Code J11.-        |
+-------------------------------------------------------------------------+
| CATEGORY J10: Identified / Confirmed Seasonal Influenza (Type A or B)   |
| - Confirmed by rapid antigen test, PCR, viral culture, or provider      |
+-------------------------------------------------------------------------+
| CATEGORY J11: Unidentified / Suspected / Clinical Influenza             |
| - Diagnosed clinically without laboratory confirmation of virus type    |
+-------------------------------------------------------------------------+

Subcategory Manifestation Structure

Categories J10 and J11 share identical 4th- and 5th-character subcategories:

• .00: Influenza with unspecified type of pneumonia (e.g., J10.00 Influenza due to other identified influenza virus with unspecified pneumonia)
• .01: Influenza with other specified pneumonia (Requires an additional code to identify the specific pneumonia/organism, e.g., J10.01 + J13 for influenza with Streptococcus pneumoniae pneumonia)
• .02: Influenza with other identified viral pneumonia (e.g., influenza with RSV pneumonia: J10.08 + J12.1)
• .1: Influenza with other respiratory manifestations (e.g., acute bronchitis J10.1 + J20.8, laryngitis, acute URI)
• .81: Influenza with encephalopathy (Influenza with acute encephalopathy/CNS manifestation)
• .82: Influenza with myocarditis
• .83: Influenza with otitis media
• .89: Influenza with other manifestations (e.g., influenza-associated myositis)

[!IMPORTANT] Official Coding Guideline Section I.C.10.c (Influenza): Code only confirmed cases of avian influenza (J09.X1–J09.X9) or other novel influenza A viruses. This is an exception to the inpatient "possible/probable/suspected" coding rule. If the provider documents "suspected avian influenza," code from category J11 (Influenza due to unidentified influenza virus). However, for seasonal influenza (J10), provider documentation that the patient has influenza is sufficient for coding without mandatory lab confirmation, provided it is not documented as novel.

Ventilator-Associated Pneumonia (VAP / J95.851)

Ventilator-Associated Pneumonia (VAP) represents a severe nosocomial infection occurring in patients undergoing invasive mechanical ventilation via endotracheal tube or tracheostomy for $>48\text{ hours}$.

Official Guideline Rules for VAP (Section I.C.10.d)

1. Explicit Provider Documentation Required: Code J95.851 (Ventilator associated pneumonia) can be assigned only when the provider explicitly documents "ventilator-associated pneumonia" or "VAP." A coder cannot cross-reference a positive endotracheal aspirate culture and mechanical ventilation to assume VAP.
2. Exclusion of General Pneumonia Codes: When J95.851 is assigned, do not assign an additional code from categories J12–J18 for the pneumonia itself, as J95.851 is a comprehensive code that fully describes the pulmonary condition.
3. Causative Organism Reporting: Assign an additional code to identify the causative organism from categories B95 (Streptococcus, Staphylococcus), B96 (Other specified bacterial agents), or B97 (Viral agents). For example:
   • VAP due to Pseudomonas aeruginosa: J95.851 + B96.5
   • VAP due to MRSA: J95.851 + B95.62
   • VAP due to Klebsiella pneumoniae: J95.851 + B96.1
4. Sequencing Guidelines:
   • VAP Developing After Admission: If a patient is admitted with another condition (e.g., traumatic brain injury S06.0-, acute myocardial infarction I21.0-, or community-acquired pneumonia J18.9) and subsequently develops VAP during mechanical ventilation, the admission condition is sequenced as the principal diagnosis, and J95.851 is coded as a secondary diagnosis (POA = "N").
   • Patient Admitted with Existing VAP: If a patient is transferred from an outside acute care hospital specifically for treatment of established VAP, J95.851 may be sequenced as the principal diagnosis.
5. Patient with Admission Pneumonia Developing VAP: If a patient is admitted with community-acquired pneumonia (J18.9, POA = "Y") and, after being placed on mechanical ventilation, subsequently develops ventilator-associated pneumonia, both codes are assigned: J18.9 (PDX, POA = "Y") and J95.851 (Secondary, POA = "N"), along with the organism code for the VAP.